analysts News
Most Popular analysts Story
Will looming drug approval make AMAG a buyout target?
After nearly three decades of drug development work, AMAG Pharmaceuticals appears poised to gain an FDA approval for its first product. And a group of analysts have been providing the company with a... Read more...
Latest Headlines
- April 30, 2009
- April 30, 2009
- April 17, 2009
- January 6, 2009
- December 17, 2008
- November 19, 2008
- November 17, 2008
- February 11, 2008
- December 3, 2007
- November 26, 2007
- November 21, 2007
- November 20, 2007
- November 19, 2007
- November 14, 2007
- November 6, 2007
- November 5, 2007
- October 29, 2007
- October 8, 2007
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
